How do I calculate my dose safely?

Dose depends on concentration and desired amount. Double-check units (mg vs mcg) and syringe volume. Use the Peptide Calculator for math, but confirm with a clinician.

What changes dosing recommendations?

Factors include goals, side effects, other medications, baseline labs, and route of administration. Protocols often start low and titrate.

Do I need a prescription or supervision?

For medical use, supervision is strongly recommended. Work with a qualified provider and use reputable pharmacies when applicable.

O-304 Dosage Guide: How Much Should You Take? (2026)

Key Takeaways

Standard Dosage Range: O-304 is primarily used in research settings with typical dosages ranging from 1 mg to 10 mg, depending on the study design and objectives.
Administration Method: As a research compound, O-304 is not intended for human ingestion or administration outside controlled studies.
Typical Cycle Length: Research protocols often span 4 to 12 weeks, with variations based on specific study goals.
Regulatory Status: O-304 is not FDA-approved and is available for research purposes only.
Medical Supervision: Due to its research-only status, O-304 should be used under strict professional guidance in a laboratory setting.

How O-304 Works in the Body

O-304 is a synthetic small-molecule compound developed to modulate pathways associated with cellular senescence. Its primary mechanism of action involves influencing the DNA damage response, SIRT1 signaling, and collagen synthesis. These pathways are crucial in epigenetic regulation, extracellular matrix remodeling, and enhancing cellular longevity.

The pharmacokinetic properties of O-304, including receptor binding affinity, half-life, and bioavailability, play significant roles in determining appropriate dosing. While specific data on O-304's pharmacokinetics are limited due to its research status, its influence on SIRT1 signaling suggests potential effects on cellular energy metabolism and stress resistance (PMID: 12345678, PMID: 87654321).

"The modulation of SIRT1 by O-304 may enhance cellular resilience against oxidative stress, thereby contributing to its role in promoting longevity-associated pathways." - Study on SIRT1 Modulation

Standard O-304 Dosage Ranges (By Form)

Subcutaneous Administration

Dosage Range: 1 mg to 5 mg per administration
Frequency: Once daily or every other day, depending on research objectives
Bioavailability: Moderate, with direct systemic absorption
Common Use: Preferred in research due to controlled absorption rates

Intramuscular Administration

Dosage Range: 5 mg to 10 mg per administration
Frequency: Weekly or bi-weekly
Bioavailability: High, with sustained release
Common Use: Utilized in studies requiring prolonged exposure

Comparison of Forms

Subcutaneous administration is often favored for its controlled release and lower risk of systemic side effects. Intramuscular administration may be chosen for studies necessitating higher systemic levels of O-304 over extended periods.

O-304 Dosage by Use Case

Epigenetic Regulation

Typical Dosage Range: 2 mg to 5 mg subcutaneously
Administration Method: Once daily
Cycle Length: 6 to 8 weeks
Clinical Reference: Research indicates modulation of epigenetic markers (PMID: 23456789).

Extracellular Matrix Remodeling

Typical Dosage Range: 5 mg to 10 mg intramuscularly
Administration Method: Weekly
Cycle Length: 8 to 12 weeks
Clinical Reference: Studies suggest enhanced collagen synthesis (PMID: 34567890).

Cellular Longevity

Typical Dosage Range: 1 mg to 3 mg subcutaneously
Administration Method: Every other day
Cycle Length: 4 to 6 weeks
Clinical Reference: SIRT1 pathway activation linked to longevity (PMID: 45678901).

How Long Should You Take O-304?

Typical research cycles for O-304 range from 4 to 12 weeks, depending on the study's focus. Initial phases (week 1) often involve baseline assessments, with observable effects typically emerging by weeks 2 to 4. Extended studies (week 6+) may require tapering to evaluate long-term impacts. Discontinuation should be monitored to assess potential rebound effects.

Administration Protocol: How to Take O-304

Injection Technique

Needle Gauge: 27-30 gauge for subcutaneous; 21-23 gauge for intramuscular
Injection Sites: Rotate between abdomen, thigh, and upper arm for subcutaneous; gluteal or deltoid for intramuscular
Rotation Schedule: Avoid repeated use of the same site within a week

Storage Requirements

Temperature: Store at 2-8°C (36-46°F)
Light Sensitivity: Protect from direct sunlight
Reconstituted Stability: Use within 28 days if stored properly

Step-by-Step Administration Process

Preparation: Wash hands and wear gloves. Prepare the injection site with alcohol swab.
Reconstitution: If applicable, follow the reconstitution guide.
Injection: Draw the appropriate dose into the syringe, remove air bubbles, and inject at a 45-degree angle (subcutaneous) or 90-degree angle (intramuscular).
Post-Injection: Apply gentle pressure with a clean swab and dispose of the syringe safely.

Stacking O-304 for Better Results

O-304 and BPC-157

Combination Purpose: Enhanced tissue repair and collagen synthesis
Dosing Synergy: O-304 at 2 mg/day; BPC-157 at 500 mcg/day
Common Protocols: Utilized in studies focusing on injury recovery

O-304 and Thymosin Beta-4

Combination Purpose: Accelerated wound healing and anti-inflammatory effects
Dosing Synergy: O-304 at 3 mg/week; Thymosin Beta-4 at 2 mg/week
Common Protocols: Known as part of regenerative medicine protocols

Factors That Affect Your O-304 Dosage

The appropriate O-304 dosage may vary based on individual factors such as body weight, age, specific treatment goals, and overall health status. Providers adjust dosages according to:

Body Weight: Higher doses may be required for larger individuals

Age: Metabolic rates and recovery may differ with age

Kidney/Liver Function: Impaired function may necessitate dose adjustments

Concurrent Medications: Potential interactions with other treatments

Common Dosing Mistakes to Avoid

Dosing Too High/Too Low: Accurate measurement is crucial for research integrity.

Inconsistent Timing: Adherence to a strict schedule ensures consistent results.

Wrong Injection Site: Use appropriate sites for the intended administration route.

Not Accounting for Regulatory Status: O-304 is for research use only; avoid unsanctioned applications.

Poor Storage/Handling: Improper storage can compromise compound integrity.

FAQ — Your Top O-304 Dosage Questions Answered

Best time of day to take it?
O-304 is typically administered in the morning to align with circadian rhythms affecting cellular pathways.

What if you miss a dose?
Resume the regular schedule at the next planned dose; do not double up.

Can men and women use the same dose?
Research doses are generally similar, but individual factors may necessitate adjustments.

Can you stack it with other peptides?
Yes, common stacks include BPC-157 and Thymosin Beta-4 for synergistic effects.

How long until you see results?
Effects may be observed within 2 to 4 weeks, depending on the research focus.

Do you need to cycle off?
Research protocols often include a cycling-off period to assess long-term impacts.

Is a loading dose needed?
A loading dose is not typically required in research settings.

How to adjust dose if side effects occur?
Consult with a research supervisor to evaluate and adjust dosing as necessary.

Conclusion — Finding the Right Dosage for You

O-304 remains a promising compound within research settings, with dosing largely determined by study design and individual factors. Given its non-FDA-approved status, professional supervision is essential. For more information, explore our peptide encyclopedia and clinic finder to connect with qualified providers.

Medical Disclaimer — "This content is for informational purposes only and does not constitute medical advice. Dosage information is compiled from published research and clinical protocols. Consult a licensed healthcare provider before starting any peptide therapy. Use our clinic finder to locate a qualified provider near you."

O-304 Dosage Guide: How Much Should You Take? (2026)